PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Social Anxiety 3,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.63
Hormone Replacement Therapy 11,020 Disease Target AACT 109 1 0.00 -1.00 0.01 0.60
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Chronic Obstructive Pulmonary Disease 27,780 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Tuberculosis 146,217 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Infection 766,637 Disease Target AACT 109 1 0.00 -1.00 0.01 0.50
Cancer 1,053,491 Disease Target ACAD8 11 1 0.00 -0.95 0.09 0.54
Psychiatric Disorder 6,440 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.61
Diarrhea 51,986 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Prostate Cancer 71,064 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Schizophrenia 77,034 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.54
Platelet Aggregation 25,460 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.58
Lung Cancer 91,416 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.55
Gonorrhea 5,642 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.61
Arrhythmia 29,330 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.57
Analgesia 44,857 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.56
Cancer 1,053,491 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.49
Hormone Replacement Therapy 11,020 Disease Target ACTG1 41 1 0.00 -0.99 0.02 0.61
Gout 8,355 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.63
Ovarian Cancer 33,996 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.59
Arthritis 128,324 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.57
Stroke 146,992 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
Cholesterol 182,390 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
Carcinoma 433,099 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.54
Non Small Cell Lung Cancer 28,563 Disease Target ACY1 51 1 0.00 -0.99 0.02 0.59
Prostate Cancer 71,064 Disease Target ACY1 51 1 0.00 -0.99 0.02 0.56
Infection 766,637 Disease Target ACY1 51 1 0.00 -0.99 0.02 0.52
Obesity 138,233 Disease Target ADRBK1 10 1 0.00 -0.95 0.10 0.58
Diabetes 332,602 Disease Target ADRBK1 10 1 0.00 -0.95 0.10 0.56
Hypertriglyceridemia 7,877 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.57
Gallstones 8,280 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.57
Dyslipidemia 15,225 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.56
Constipation 15,810 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.56
Inflammatory Bowel Disease 24,375 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.55
Hyperglycemia 28,168 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.54
Hearing Loss 30,622 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.54
Schizophrenia 77,034 Disease Target ADRP 537 1 0.00 -1.00 0.00 0.52
Seizure 44,685 Disease Target ADSF 11 1 0.00 -0.95 0.09 0.60